Class information for:
Level 1: VIRAL ONCOLYSATE//CELLULAR IMMUNOL D010//MTH 68 H

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
21115 372 41.2 71%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
151 22214 IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 VIRAL ONCOLYSATE Author keyword 6 80% 1% 4
2 CELLULAR IMMUNOL D010 Address 6 100% 1% 4
3 MTH 68 H Author keyword 3 100% 1% 3
4 ABT ZELLULARE IMMUNOL Address 2 67% 1% 2
5 AF2240 Author keyword 2 67% 1% 2
6 NEWCASTLE DISEASE VIRUS NDV Author keyword 2 27% 2% 7
7 HEMAGGLUTININ NEURAMINIDASE Author keyword 1 17% 2% 8
8 ABT 0710 Address 1 100% 1% 2
9 ABT ZELLULARE IMMUNOL G0100 Address 1 100% 1% 2
10 CD3 AND CD28 CROSS LINKING Author keyword 1 100% 1% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 VIRAL ONCOLYSATE 6 80% 1% 4 Search VIRAL+ONCOLYSATE Search VIRAL+ONCOLYSATE
2 MTH 68 H 3 100% 1% 3 Search MTH+68+H Search MTH+68+H
3 AF2240 2 67% 1% 2 Search AF2240 Search AF2240
4 NEWCASTLE DISEASE VIRUS NDV 2 27% 2% 7 Search NEWCASTLE+DISEASE+VIRUS+NDV Search NEWCASTLE+DISEASE+VIRUS+NDV
5 HEMAGGLUTININ NEURAMINIDASE 1 17% 2% 8 Search HEMAGGLUTININ+NEURAMINIDASE Search HEMAGGLUTININ+NEURAMINIDASE
6 CD3 AND CD28 CROSS LINKING 1 100% 1% 2 Search CD3+AND+CD28+CROSS+LINKING Search CD3+AND+CD28+CROSS+LINKING
7 HEMAGGLUTININ NEURAMINIDASEHN 1 100% 1% 2 Search HEMAGGLUTININ+NEURAMINIDASEHN Search HEMAGGLUTININ+NEURAMINIDASEHN
8 NEWCASTLE DISEASE VIRUS AF2240 1 100% 1% 2 Search NEWCASTLE+DISEASE+VIRUS+AF2240 Search NEWCASTLE+DISEASE+VIRUS+AF2240
9 VENEZUELAN ENCEPHALOMYELITIS VIRUS 1 100% 1% 2 Search VENEZUELAN+ENCEPHALOMYELITIS+VIRUS Search VENEZUELAN+ENCEPHALOMYELITIS+VIRUS
10 HN GENE 1 30% 1% 3 Search HN+GENE Search HN+GENE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 POSTOPERATIVE IMMUNOTHERAPY 47 88% 6% 22
2 ANTITUMOR VACCINATION 29 88% 4% 14
3 VACCINE MTH 68 H 21 90% 2% 9
4 NDV HUJ 12 86% 2% 6
5 II MALIGNANT MELANOMA 11 56% 4% 14
6 ONCOLYTIC VIRUS 6 24% 5% 20
7 ONCOLYTIC PROPERTIES 6 100% 1% 4
8 METASTATIC SPREAD 5 24% 5% 19
9 PV701 5 63% 1% 5
10 MODIFIED TUMOR CELLS 3 43% 2% 6

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy 2011 10 71 76%
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions 2012 23 155 54%
Immunization with virus-modified tumor cells 1998 64 45 62%
Newcastle disease virus as an oncolytic agent 2009 16 46 48%
Newcastle disease virus (NDV): brief history of its oncolytic strains 2000 110 90 22%
Expressing foreign genes by Newcastle disease virus for cancer therapy 2015 0 46 63%
T-cell priming in bone marrow: the potential for long-lasting protective anti-tumor immunity 2003 31 56 48%
Complete remission of cancer in late-stage disease by radiation and transfer of allogeneic MHC-matched immune T cells: lessons from GvL studies in animals 2014 0 31 52%
Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function 2014 1 103 29%
Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus 2007 47 22 18%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CELLULAR IMMUNOL D010 6 100% 1.1% 4
2 ABT ZELLULARE IMMUNOL 2 67% 0.5% 2
3 ABT 0710 1 100% 0.5% 2
4 ABT ZELLULARE IMMUNOL G0100 1 100% 0.5% 2
5 AFFILIATED TUMOR HOSPHUNAN PROV TUMOR HOSP 1 50% 0.3% 1
6 BIOPHARMACEUT TEACHING SECT 1 50% 0.3% 1
7 CELLULAR IMMUNOL 0710 1 50% 0.3% 1
8 GENDER MOL IMAGING 1 50% 0.3% 1
9 INNATE IMMUN JR GRP 1 50% 0.3% 1
10 MIL MED SCI 11 1 50% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000167753 ONCOLYTIC VIRUS//VIROTHERAPY//ONCOLYTIC ADENOVIRUS
2 0.0000150906 NEWCASTLE DISEASE VIRUS//NEWCASTLE DISEASE//AVIAN PARAMYXOVIRUS
3 0.0000095521 TUMOR BEARING STATE//AUTOIMMUNOTHERAPY//CD8 CELL REACTIVITY
4 0.0000081269 CHIMERIC ANTIBODY 311//COLON CANCER ANTIGENS//HJ TAGNON
5 0.0000073975 GEL FIBERGLASS//TERATOL EXPT ONCOL//RAT COLON CANCER
6 0.0000067024 BIOCHEMOTHERAPY//METASTATIC MELANOMA//DACARBAZINE
7 0.0000062315 TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//AUTOLYMPHOCYTE THERAPY
8 0.0000062003 ADV CELL MOL THER Y//SHUNDE PEOPLES HOSP//TUMOR VACCINE
9 0.0000061856 ANTIGEN SHEDDING//ADOPTIVE CHEMOIMMUNOTHERAPY//DRUG RESISTANT TUMORS
10 0.0000059868 2HB ANTIGEN//CIENCIAS BIOQUIM ARTADO 644//DELAYED HYPERSENSITIVITY SKIN TEST